For research use only. Not for therapeutic Use.
FC9402 is a potent and selective sulfide quinone oxidoreductase (SQOR) inhibitor extracted from patent WO 2020/146636 A1. FC9402 attenuates TAC-induced cardiomyocyte hypertrophy and left ventricle (LV) fibrosis. FC9402 can be used for cardiovascular regulation[1].
FC9402 attenuates TAC-induced cardiomyocyte hypertrophy and left ventricle (LV) fibrosis[1].
| Catalog Number | I045262 |
| CAS Number | 2452401-65-7 |
| Synonyms | 4-(4-aminophenyl)-2-methoxy-6-(3-methylpyridin-2-yl)pyridine-3-carbonitrile |
| Molecular Formula | C19H16N4O |
| Purity | ≥95% |
| InChI | InChI=1S/C19H16N4O/c1-12-4-3-9-22-18(12)17-10-15(13-5-7-14(21)8-6-13)16(11-20)19(23-17)24-2/h3-10H,21H2,1-2H3 |
| InChIKey | FSYJNCHUENWJEE-UHFFFAOYSA-N |
| SMILES | CC1=C(N=CC=C1)C2=NC(=C(C(=C2)C3=CC=C(C=C3)N)C#N)OC |
| Reference | [1]. WO 2020/146636 A1 |
